Brett Matthew Hall insider trades

Open-market stock purchases and sales by Brett Matthew Hall, CHIEF SCIENTIFIC OFFICER at Immuneering Corp, from SEC Form 4 filings since Aug 3, 2021.

Track record: 71% of 7 scored buys are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
Jun 15, 2026IMRX Immuneering CorpBought$25K
Feb 3, 2026IMRX Immuneering CorpBought (not open market)—
Jan 15, 2026IMRX Immuneering CorpBought$10.5K

Companies traded

  • IMRX Immuneering Corp: 8 buys, last Jun 15, 2026

Get free alerts when Brett Matthew Hall files a new trade →